Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.71

+0.4%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jayhawk969 who wrote (3147)	3/20/2001 8:42:20 PM
From: IRWIN JAMES FRANKEL	Read Replies (3) of 52153

Update of Cash to Price table of selected biotechs. [w/ JD additions] CVTX with 63% of its price represented by cash is just one interesting example. Here is a rundown on where the ones I like are selling (P), their high (H), percent of high, cash p/s (C) and C/P. The numbers are from Yahoo and I have not tried to verify the data - so if one interests you do some DD. SYM -- P -- H -- %H -- C -- C/P ABGX 17 103 17% 9 53% ALXN 20 119 16 21 105 CALP 16 196 8 6 38 CEGE 14 72 29 23 164 CORR 24 67 35 6 25 CRGN 20 69 29 11 55 CVTX 24 93 26 15 63 HGSI 43 106 41 15 35 INCY 13 72 18 9 69 ITMN 16 56 29 8 50 LEXG 8 49 16 4 50 MEDX 15 100 15 5 33 MLNM 25 90 28 7 28 NBIX 15 47 32 7 47 NPSP 25 58 43 9 36 PCYC 23 85 27 8 35 PDLI 38 146 26 15 39 SEPR 30 140 21 9 30 VPHM 26 111 23 14 54 VRTX 32 99 32 12 38 These stocks are high beta and thus risky. (ML according to posts has suggested near term risk for SEPR down to 28-32.) Looks like ML got it right on SEPR dropping to 30. I am leery of the CEGE cash. Do they really have 164% of their market cap in cash???? That seems odd even in this depressed period. Happy hunting. ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next